Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Operating Margin for Marinus Pharmaceuticals (MRNS)
Operating Margin as of May 2024 (TTM): -64.47%
According to Marinus Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -64.47%. At the end of 2021 the company had an Operating Margin of -643.70%.
Operating Margin history for Marinus Pharmaceuticals from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -643.70% | -83.61% |
| 2020 | -3,927.53% | |
| 2012 | -1,408.55% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | 9.10% | -114.12% | 🇺🇸 USA |
 Endo International
ENDPQ | -129.15% | 100.33% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | 0.00% | N/A | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | 21.96% | -134.06% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.